Eli Lilly Pharmaceutical Manufacturing Facility, Kinsale – Pharmaceutical Technology #pharma #suppliers

Posted On May 3 2017 by

#lilly pharma # Eli Lilly Pharmaceutical Manufacturing Facility, Kinsale Order year 2006 Construction started April 2008 Project type Biotech manufacturing facility Location Kinsale, Ireland Estimated investment 400m Completion June 2010 Construction completed 2010 In December 2006 Eli Lilly made a commitment to invest around $400m in a biologics manufacturing facility. The IE42 bio-technology manufacturing facility is located at the company’s Kinsale site near Dunderrow in County Cork. The site amounts to 20.96 hectares. The Kinsale site is one of six bulk manufacturing sites for Eli Lilly worldwide. It first opened in 1981 and currently employs about 450 personnel, who are …


Shionogi Pharmaceutical Research Facility, Osaka – Pharmaceutical Technology #pharmaceutical #companies #in #los #angeles

Posted On Apr 29 2017 by

#shionogi pharma # Shionogi Pharmaceutical Research Facility, Osaka, Japan Project Type Pharmaceutical Research Facility Location Toyonaka, Osaka Construction Commenced September 2008 Completed July 2011 Operations Started August 2011 Investment ¥18.9bn ($247m) Owner Shionogi & Co Shionogi Co’s new pharmaceutical research facility is located in Toyonaka City in Osaka, Japan. The new facility was opened in August 2011. It is equipped with drug discovery research laboratories and laboratory equipment, as well as information technology capabilities. The new facility was built with an investment of about ¥18.9bn ($247m). It will serve as the main research facility for Shionogi. With the construction of …


MDS Pharma closes Quebec facility following FDA probe #biotechnology #industry

Posted On Apr 24 2017 by

#mds pharma services # MDS Pharma closes Quebec facility following FDA probe By Kirsty Barnes Kirsty Barnes 06-Feb-2007 2007-02-06T00:00:00Z MDS pharma has ceased operations at its bioanalytical services facility in Blainville, Quebec in a bid to boost profitability after an ongoing investigation of the site by the US Food and Drug Administration (FDA). The restructure also affects the firm’s other North American bioanalytical facilities – in St. Laurent, Montreal, which is also involved in the FDA probe, as well as its site in Lincoln, Nebraska. From now on, the former Quebec operations will be carried out from the Montreal facility, …


German pharmaceutical firm strikes state deal for Des Plaines facility – Chicago Tribune #cmc #pharma

Posted On Apr 23 2017 by

#pharmaceutical companies in chicago # German pharmaceutical firm strikes state deal for Des Plaines facility A German pharmaceutical manufacturer plans to build a production facility in suburban Des Plaines that would create at least 300 jobs, Illinois officials said Tuesday. The project would be one of the largest economic-development victories in Des Plaines history, said City Manager Michael Bartholomew. Vetter, based in Ravensburg, Germany, has signed an economic development agreement with the state. The news release from the Department of Commerce and Economic Opportunity did not provide details of financial incentives Illinois plans to give Vetter. A department spokeswoman was …


Shionogi Pharmaceutical Research Facility, Osaka – Pharmaceutical Technology #pharma #consultants

Posted On Apr 20 2017 by

#shionogi pharma # Shionogi Pharmaceutical Research Facility, Osaka, Japan Project Type Pharmaceutical Research Facility Location Toyonaka, Osaka Construction Commenced September 2008 Completed July 2011 Operations Started August 2011 Investment ¥18.9bn ($247m) Owner Shionogi & Co Shionogi Co’s new pharmaceutical research facility is located in Toyonaka City in Osaka, Japan. The new facility was opened in August 2011. It is equipped with drug discovery research laboratories and laboratory equipment, as well as information technology capabilities. The new facility was built with an investment of about ¥18.9bn ($247m). It will serve as the main research facility for Shionogi. With the construction of …


Eli Lilly Pharmaceutical Manufacturing Facility, Kinsale – Pharmaceutical Technology #pharma #regulatory

Posted On Apr 15 2017 by

#lilly pharma # Eli Lilly Pharmaceutical Manufacturing Facility, Kinsale Order year 2006 Construction started April 2008 Project type Biotech manufacturing facility Location Kinsale, Ireland Estimated investment 400m Completion June 2010 Construction completed 2010 In December 2006 Eli Lilly made a commitment to invest around $400m in a biologics manufacturing facility. The IE42 bio-technology manufacturing facility is located at the company’s Kinsale site near Dunderrow in County Cork. The site amounts to 20.96 hectares. The Kinsale site is one of six bulk manufacturing sites for Eli Lilly worldwide. It first opened in 1981 and currently employs about 450 personnel, who are …


Eli Lilly Pharmaceutical Manufacturing Facility, Kinsale – Pharmaceutical Technology #names #of #pharmaceutical #companies

Posted On Apr 7 2017 by

#lilly pharma # Eli Lilly Pharmaceutical Manufacturing Facility, Kinsale Order year 2006 Construction started April 2008 Project type Biotech manufacturing facility Location Kinsale, Ireland Estimated investment 400m Completion June 2010 Construction completed 2010 In December 2006 Eli Lilly made a commitment to invest around $400m in a biologics manufacturing facility. The IE42 bio-technology manufacturing facility is located at the company’s Kinsale site near Dunderrow in County Cork. The site amounts to 20.96 hectares. The Kinsale site is one of six bulk manufacturing sites for Eli Lilly worldwide. It first opened in 1981 and currently employs about 450 personnel, who are …


German pharmaceutical firm strikes state deal for Des Plaines facility – Chicago Tribune #pharma #pharmaceutical #company

Posted On Mar 24 2017 by

#pharmaceutical companies in chicago # German pharmaceutical firm strikes state deal for Des Plaines facility A German pharmaceutical manufacturer plans to build a production facility in suburban Des Plaines that would create at least 300 jobs, Illinois officials said Tuesday. The project would be one of the largest economic-development victories in Des Plaines history, said City Manager Michael Bartholomew. Vetter, based in Ravensburg, Germany, has signed an economic development agreement with the state. The news release from the Department of Commerce and Economic Opportunity did not provide details of financial incentives Illinois plans to give Vetter. A department spokeswoman was …


Eli Lilly Pharmaceutical Manufacturing Facility, Kinsale – Pharmaceutical Technology #outsourcing #pharma

Posted On Feb 9 2017 by

#lilly pharma # Eli Lilly Pharmaceutical Manufacturing Facility, Kinsale Order year 2006 Construction started April 2008 Project type Biotech manufacturing facility Location Kinsale, Ireland Estimated investment 400m Completion June 2010 Construction completed 2010 In December 2006 Eli Lilly made a commitment to invest around $400m in a biologics manufacturing facility. The IE42 bio-technology manufacturing facility is located at the company’s Kinsale site near Dunderrow in County Cork. The site amounts to 20.96 hectares. The Kinsale site is one of six bulk manufacturing sites for Eli Lilly worldwide. It first opened in 1981 and currently employs about 450 personnel, who are …


German pharmaceutical firm strikes state deal for Des Plaines facility – Chicago Tribune #new #pharmaceuticals

Posted On Feb 5 2017 by

#pharmaceutical companies in chicago # German pharmaceutical firm strikes state deal for Des Plaines facility A German pharmaceutical manufacturer plans to build a production facility in suburban Des Plaines that would create at least 300 jobs, Illinois officials said Tuesday. The project would be one of the largest economic-development victories in Des Plaines history, said City Manager Michael Bartholomew. Vetter, based in Ravensburg, Germany, has signed an economic development agreement with the state. The news release from the Department of Commerce and Economic Opportunity did not provide details of financial incentives Illinois plans to give Vetter. A department spokeswoman was …